Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab therapy in steroid-resistant active thyroid-associated ophthalmopathy
2011-000899-33Phase 4Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Jun 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rituximab in Graves Orbitopathy (GO), sponsored by Sahlgrenska University Hospital. Primary endpoint: CAS responder rate. Started Jun 2011; status: completed.
02
Drugs
rituximab
03
Conditions
Graves Orbitopathy (GO)
Beyond the preview
Go deeper on 2011-000899-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000899-33.